The Psychological Toll of Parkinson’s Disease: Depression, Anxiety & Cognitive Decline

There is a sense of urgency to know about the psychological component of Parkinson’s disease because bodily symptoms are well known, and affective and cognitive symptoms are overlooked. Neuropsychiatric symptoms are responsible for a rapid deterioration in the patient’s quality of life and misery, with almost half of them suffering from depression and approximately 40% suffering from anxiety (www.thelancet.com). Cognitive impairment may emerge in up to 80% of patients in the long term, aggravating emotional disturbances and draining caregivers. Healthcare providers use biopsychosocial evaluation to integrate biological, psychological, and social elements in PD care. The identification of these elements is advantageous to both patients and caregivers by synchronising support systems to improve overall quality of life.

The Emotional Landscape of Parkinson’s Disease

1. The Silent Struggle: Depression and Anxiety in PD

Depression is an overbearing and dramatic neuropsychiatric symptom that occurs in PD patients. Studies have established that close to 50% of PD individuals will experience some form of depression at some point throughout the disease, underscoring how much of a prevalent condition it is in such persons (Depression | Parkinson’s Foundation, 2025). Moreover, mood disorders have been established to be one of the most frequently reported of the non-motor symptoms, with certain research placing estimates as high as 96.4% in some cohorts of PD (Khedr et al., 2020).

Unfortunately, these depressive symptoms are not rendered visible since they are mixed with motor symptoms, resulting in a long and difficult process of proper diagnosis (Ray & Agarwal, 2019). In addition, untreated depression will lead to increased functional impairment and caregiver burden, again suggesting that the condition must be diagnosed and treated early. The multifactorial pathophysiology of PD engages most of the biological processes in the development and maintenance of PD depression. This necessitates an integrative model of psychiatric treatment best supplemented by motor symptom management.

2. Anxiety in Parkinson’s Disease

Anxiety is a common non-motor manifestation of PD in approximately 40% of patients. It occurs as generalised anxiety, panic attacks, and phobias, and most develop anticipatory anxiety when confronted with situations that require high-order cognitive function or uncertainty regarding their disease. Anxiety leads to cognitive impairment by impairing attention, fracturing memory, and disturbing executive function. It is typically linked to the severity of anxiety symptoms and movement difficulties, with patients experiencing more severe anxiety reporting greater motion problems.

Besides, anxiety has also resulted in social withdrawal because anxious patients will avoid initiating things. It can be treated with psychotherapy and medication, but is left undiagnosed and untreated in most, and therefore their quality of life is impaired (Depression | Parkinson’s Foundation, 2025; Marsh, 2013). Healthcare providers need to treat these symptoms as part of the overall management of PD.

3. The Shadow of Apathy: A Hidden Symptom

Apathy is an important non-motor symptom of Parkinson’s disease (PD) that strongly interferes with patients’ motivation and activity levels. The syndrome manifests through goal-directed behaviour reduction, predominantly in the form of subjective experience of indifference, reduced interest, and absence of affective engagement. Evidence proves how apathy extends to as many as 93% of PD patients and is responsible for its prevalence, and is a characteristic of the typical clinical presentation of the illness (Meyer et al., 2015).

Notably, apathy has been attributed to executive dysfunction in the initiation domain, thus mirroring its complex association with cognition (Meyer et al., 2015). As opposed to depression, which is found with PD in most cases, apathy seems to be an entity in itself; hence, clinicians should dissociate the two in patient evaluation (www.thelancet.com). In addition, the evidence suggests that age and gender traits can be potential determinants for patient apathy levels: older men are more vulnerable to apathy, and older women are perhaps somewhat resistant.

The Cognitive Challenge: Coping with Mental Decline

1. A Mental Confusion: A Description of Cognitive Changes

Cognitive impairment is increasingly impacting most Parkinson’s Disease patients, even in early stages of the disease. Executive dysfunction is prevalent (Dirnberger & Jahanshahi, 2013) and is responsible for impairments in attention, planning, and decision-making, impacting quality of life. Cognitive impairment depends on factors like age, gender, and comorbid illnesses like depression. Neurobiologically, cognitive impairment is associated with dysregulation of dopaminergic systems, such as the basal ganglia and neuroinflammatory processes (Degirmenci et al., 2023). Up to 80% of PD patients carry the risk of experiencing cognitive decline in the long term (Foley & Mobley, 2024), and executive dysfunction further enables caregiver burden by increased dependency on care. Fixing these issues is crucial in the optimisation of patient care and quality of life.

2. Dysfunctional Command Centre: The Impact of Executive Dysfunction

Executive dysfunction is a highly prevalent and disabling cognitive disorder that is seen in patients with Parkinson’s disease (PD). It may manifest as difficulty with dealing with tasks of attention, planning, set-shifting, and decision-making, at times even being observed in the early stages of the disease. It has been uncovered by studies that virtually one-third of patients may have executive dysfunction at presentation, and the incidence is significantly higher when the illness progresses. Of significant mention is that the cognitive impairment has also been shown to be linked with increased caregiver burden and decreased quality of life for patients and caregivers. Executive dysfunction has more than merely cognitive effects; it is also detrimental to daily functioning and autonomy.

These symptoms may undermine a patient’s instrumental activities of daily living (ADLs) required for the maintenance of autonomy (Calleo et al., 2011). The variable effect of dopaminergic therapy on these deficits can sometimes restore some difficulties but exacerbate others (Dirnberger & Jahansahi, 2013). Its association with other non-motor symptoms makes it pertinent in the general clinical picture of PD.

3. The Wiring of the Brain: Elucidating Pathologic Mechanisms

Parkinson’s Disease (PD) cognitive impairment is irretrievably entangled with dopaminergic dysfunction, primarily due to loss of neurons secreting dopamine in the substantia nigra. That neuronal loss seriously disables frontostriatal circuitry utilised in executive functioning, working memory, and decision-making (Fang et al., 2020). Damage to cognition is not merely by dopaminergic systems, yet dysregulation of the cholinergic system is a major contributor. Interruption of cholinergic neurotransmission has the potential to exacerbate cognitive impairment, hypothesising a multifactorial causation (Degirmenci et al., 2023).

Apart from that, neuroinflammation and oxidative stress are also important factors in PD cognitive impairment (Cognitive Disorders, 2025). When glial cells are activated, they release pro-inflammatory cytokines that damage neurons. Besides, amyloid beta deposition and Lewy body pathology further detail the neurobiological complexity of cognitive impairment (Gonzalez-Latapi et al., 2021). Healthcare providers need to understand them to develop appropriate treatment plans for patients with cognitive impairment.

A Shared Path: The Psychosocial Influence on Caregivers and Patients

1. The View of the Patient: Well-Being and Quality of Life

Parkinson’s Disease (PD) influences people significantly with motor and non-motor symptoms. Mood issues, depression and anxiety are common among PD patients and have a large impact on well-being. (Khedr et al., 2020) reasserts an inversely related association of such emotional difficulty with quality of life (QOL), depression being the largest predictor of worsening QOL at onset. Cognitive impairment interferes with everyday functioning and self-sufficiency, making social interaction and simple activities difficult. Apathy, present in up to 93% of patients, dulls motivation and adds to the disruption of mental status. Early recognition and management of these psychological factors are important to maximise patient well-being and QOL in PD.

2. Shouldering the Burden: The Caregiver’s Emotional Burden

Caregivers of persons with Parkinson’s Disease (PD) shouldered a high emotional and psychological burden, given the complexity of the disease. The weight of coping with an overload of symptoms—ranging from physical deterioration to neuropsychiatric issues—usually creates undue stress and anxiety levels in such caregivers. There is also empirical evidence to suggest that most caregivers are equally affected by helplessness, isolation, and depression as they are by their exceedingly worthwhile caregiving role (Calne, 2003).

Additionally, psychological distress can also be exacerbated by cognitive impairment in patients as well as challenging behavioural symptoms such as apathy or impulsivity (Foley & Mobley, 2024). The caregivers get mentally exhausted in caring for the individuals they care for, and hence, the patient and caregiver are both exposed to psychological issues. Caregiver burden models put the importance of support groups and respite into the picture, which can assist in transferring some of these emotional burdens (Gregory Pontone & Weiss, 2018).

The Restless Night: Sleep Disturbances in PD

1. When Sleep Goes Awry: Typical Disturbance Patterns

Sleep disturbance in patients with Parkinson’s Disease appears in numerous different forms and can really take a toll on their overall quality of life. Sleep difficulty and sleep maintenance, also referred to as insomnia, occur in about two-thirds of PD patients and are one of the prevalent conditions. Another very common condition is restless legs syndrome (RLS), characterised by an irresistible urge to move the legs at rest and usually causing distress and breaking sleep. Additionally, REM sleep behaviour disorder (RBD) will typically be apparent in such people; when a bout takes place, they will be physically moving their limbs during dreams, and this may at times hurt them or their sleeping partners.

Daytime drowsiness and sleep disturbances—characterised by hyperarousal that disrupts the normal course of sleep—are also common complaints. These disruptions not only rob patients of quiet nights but also play a part in the build-up of cognitive impairment and emotional issues endured by PD patients, which make their disease harder to treat (Parkinson’s Disease: Sleep Disturbances and Fatigue | Sleep, 2025; Sleep Problems with Parkinson’s Disease, 2025).

2. The Domino Effect: How Sleep Impacts Daily Life

Sleep disturbances have significant health and daily function implications in patients with Parkinson’s Disease. Frequent insomnia, excessive daytime somnolence, and REM sleep behaviour disorder result in fatigue and decreased alertness, impairing social function and responsibility (Menza et al., 2010). Progressive depression and anxiety as a consequence of impaired sleep quality cause social withdrawal. Caregivers themselves experience heightened stress, which negatively impacts their own health to protect the wards. Long-term sleep disruption has also been discovered to be linked with cognitive impairment, which makes attention and planning ability difficult in almost 80% of PD patients. Thus, relief of sleep disturbance is necessary for enhancing the quality of life in both the patient and caregiver.

Putting the Pieces Together: Theoretical Models

1. The Integrative Perspective: The Biopsychosocial Model in Action

The biopsychosocial model is applied in the description of the psychological impact of Parkinson’s Disease (PD), to studies on the interfaces among biological, psychological, and social factors. At the biological level, there is neurodegenerative change that causes motor and intellectual impairment, and these can lead to secondary psychological disorders such as depression and anxiety.

Psychologically, patient perception and coping mechanisms are a major contributing factor to adjustment to PD, where the application of adaptive strategies aids in the facilitation of maintenance of enjoyable activity. Socially, stigma and support networks—afflict nearly 60% of patients (Foley & Mobley, 2024)—influence mental well-being through fostering isolation. Person-centred is the philosophy behind intervention programs that enable emotional health and cognitive impairment, and construct social structures of support, thereby enabling practitioners to do the same (Foley & Mobley, 2024).

2. Building Resilience: How Stress-Coping Models Help

Stress-coping models are required to solve the psychological issues of patients with Parkinson’s Disease. They require perceiving the concept of coping and understanding stress, particularly because the majority of the patients have heightened anxiety that may exacerbate physical symptoms and retard daily functioning. Coping mechanisms must be used to empower individuals. Cognitive-behavioural therapy (CBT) was able to allow patients to reframe themselves in what they perceive about stress and acquire coping skills (Foley & Mobley, 2024). CBT treats anxiety and depression and increases self-management skills to improve disease resilience. Identification of individual differences in coping skills is essential. Synthesis of motor symptoms and psychological pressure allows practitioners to design individualised care in consideration of medical and psychosocial treatments.

A Path to Healing: Treatment and Intervention

1. Mindful Healing: Strategies for Emotional Challenges

Healthcare providers must implement treatment interventions to help PD patients overcome emotional challenges. Cognitive-Behavioural Therapy (CBT) is required, which reduces anxiety and depressive symptoms, evidenced by improvement due to individual and group therapy (Foley & Mobley, 2024). These therapies improve patients by improving their self-management skills. Because PD affects motor and cognitive functions in distinctive ways, healthcare providers must tailor treatment individually.

Pacing interventions may enhance participation and comprehension, maintaining standards of psychologically informed care (Foley & Mobley, 2024). Additionally, mindfulness-based therapies facilitate coping and resilience with stress, even more so in coping with uncertainty regarding PD (Jager et al., 2011). The involvement of the family members is also beneficial to the caregivers and patients since it ensures emotional recovery from within the home setting (Marsh, 2013).

2. Talk Therapy: Improving Quality of Life

Psychotherapy improves the quality of life of Parkinson’s Disease (PD) patients via psychological and emotional difficulties. Since depression affects nearly half of PD patients and anxiety affects up to 40%, treatment interventions play a crucial role in addressing these non-motor complications. Cognitive-Behavioural Therapy (CBT) beautifully transforms dangerous ways of thinking and acting, decreasing depression and anxiety and encouraging healthier ways of coping (Foley & Mobley, 2024). Other than this, psychotherapy enables patients to adapt emotionally to the diagnosis through affective processing of confusion and loss. Mindfulness therapy also fosters emotional resilience and regulation against PD stressors (Cognitive Disorders, 2025). Caregiver-involvement therapy educates caregivers on how to handle loved ones and their emotional issues.

3. Teamwork: The Power of Multidisciplinary Care

A multidisciplinary care model is a must in addressing the psychological care of PD patients. It promotes interprofessional collaboration between clinicians such as neurologists, psychologists, and occupational therapists while addressing motor and non-motor symptoms. The burden of caregivers is high; therefore, integration of psychological care is beneficial to both caregivers and patients. Proper team coordination intervenes, addressing emotions such as depression and anxiety more easily. A biopsychosocial model aims at the biological and social determinants of mental health. The use of psychological testing in daily care may allow for the early detection of psychiatric comorbidities. According to www.thelancet.com, Cognitive-Behavioural treatments in Cognitive Disorders (2025) offer active care strategies to address changing patient needs.

4. Beyond Borders: The Role of Culturally Competent Care

Culturally sensitive interventions are crucial in managing the psychological impact of Parkinson’s disease in different groups of individuals. A person’s cultural identity can significantly influence their perception of illness and experience of emotional distress. Some ethnic communities, for instance, have more stigma towards Parkinson symptoms, discouraging patients from reporting and seeking their therapeutic interventions (Foley & Mobley, 2024). Shaping treatments for psychology in relation to cultural norms not only increases motivation but also effectiveness.

Neuropsychological tests can be designed to incorporate linguistic and cultural dimensions, making them more meaningful and useful. Additionally, treatment based on individuals’ coping mechanisms utilised in some cultures can simplify emotional adjustment to the disease. A culturally responsive practice not only fosters understanding but also facilitates caregivers and patients to navigate the complexity of the disease and their own social reality in a better way, and thus introduces improved management of Parkinson’s disease.

References +

Burchill, E., Rogers, J. P., Lees, A., Conti, I., Fanshawe, J. B., Holle, C., Rengasamy, E., Lewis, G., Kane, E. J., Saini, A., Nandrha, A., Wozniak, J., Ghorab, R. M. F., Song, J., Lahmar, A., David, A. S., Zandi, M. S., Sadeq, M. A., Cross, B., … Badenoch, J. B. (2024). The impact of psychiatric comorbidity on Parkinson’s disease outcomes: A systematic review and meta-analysis. The Lancet Regional Health—Europe, 38. https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(24)00036-X/fulltext

Calleo, J., Burrows, C., & Levin, H. (2011). Cognitive Rehabilitation for Executive Dysfunction in Parkinson’s Disease: Application and Current Directions. Parkinsonism & Related Disorders, 17(Suppl 1), S97–S101. https://pmc.ncbi.nlm.nih.gov/articles/PMC3216311/

Calne, S. M. (2003). The psychosocial impact of late-stage Parkinson’s disease. Clinical Neuroscience, 10(1), 16–21. https://pubmed.ncbi.nlm.nih.gov/14713096/

Cognitive Disorders. (2025). ScienceDirect. Retrieved from https://www.sciencedirect.com/topics/neuroscience/cognitive-disorders

de Jager, C., Haigh, A. M., Ahmed-Ali, S., & Garrard, P. (2011). International Psychogeriatrics. ScienceDirect. Retrieved from https://www.sciencedirect.com/science/article/pii/S1041610224039036

Degirmenci, Y., Angelopoulou, E., Georgakopoulou, V. E., & Bougea, A. (2023). Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches. Medicina, 59(10), 1756. https://www.mdpi.com/1648-9144/59/10/1756

Depression | Parkinson’s Foundation. (2025). Parkinson’s Foundation. Retrieved from https://www.parkinson.org/understanding-parkinsons/non-movement-symptoms/depression

Dirnberger, G., & Jahanshahi, M. (2013). Executive dysfunction in Parkinson’s disease: A review. Journal of Parkinson’s Disease, 3(3), 265–294. https://pubmed.ncbi.nlm.nih.gov/24007368/

Fang, C., Lv, L., Mao, S., Dong, H., & Liu, B. (2020). Cognition Deficits in Parkinson’s Disease: Mechanisms and Treatment. BioMed Research International, 2020, Article 8175024. https://pmc.ncbi.nlm.nih.gov/articles/PMC7128056/

Foley, J. A., & Mobley, A. (2024). Psychological and Neuropsychological Services for People with Parkinson’s Disease (Draft Guidance). The British Psychological Society. https://cms.bps.org.uk/sites/default/files/2025-03/Draft%20Guidance%20-%20Psychological%20and%20Neuropsychological%20Services%20for%20People%20with%20Parkinson%E2%80%99s%20Disease.pdf

Gonzalez-Latapi, P., Bayram, E., Litvan, I., & Marras, C. (2021). Cognitive Impairment in Parkinson’s Disease: Epidemiology, Clinical Profile, Protective and Risk Factors. Current Treatment Options in Neurology, 23(6), 18. https://pmc.ncbi.nlm.nih.gov/articles/PMC8152515/

Khedr, E. M., Abdelrahman, A. A., Elserogy, Y., Zaki, A. F., & Gamea, A. (2020). Depression and anxiety among patients with Parkinson’s disease: Frequency, risk factors, and impact on quality of life. Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 56(1), Article 78. https://ejnpn.springeropen.com/articles/10.1186/s41983-020-00253-5

Marsh, L. (2013). Depression and Parkinson’s Disease: Current Knowledge. Current Treatment Options in Neurology, 15(2), 226–237. https://pmc.ncbi.nlm.nih.gov/articles/PMC4878671/

Menza, M., Dobkin, R. D., Marin, H., & Bienfait, K. (2010). Sleep Disturbances in Parkinson’s Disease. Current Treatment Options in Neurology, 12(4), 304–311. https://pmc.ncbi.nlm.nih.gov/articles/PMC2840057/

Meyer, A., Schwarz, N., Gschwandtner, U., Hatz, F., Zimmermann, R., Fuhr, P., & Bousleiman, H. (2015). Apathy in Parkinson’s disease is related to executive function, gender and age but not to depression. Frontiers in Ageing Neuroscience, 6, Article 350. https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2014.00350/full

Parkinson’s Disease: Sleep Disturbances and Fatigue | Sleep. (2025). Sleep Foundation. Retrieved from https://www.sleepfoundation.org/physical-health/parkinsons-disease-and-sleep

Pontone, G., & Weiss, H. (2018). Mental Health and Parkinson’s Disease. Practical Neurology. Retrieved from https://practicalneurology.com/diseases-diagnoses/movement-disorders/mental-health-and-parkinsons-disease/30246/

Ray, S., & Agarwal, P. (2019). Depression and Anxiety in Parkinson’s Disease. Missouri Medicine, 116(6), 496–502. https://pubmed.ncbi.nlm.nih.gov/31733705/

Sleep Problems with Parkinson’s Disease. (2025). Cleveland Clinic. Retrieved from https://my.clevelandclinic.org/health/articles/9366-sleep-problems-with-parkinsons-disease